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Legal and Ethical Considerations for 
COVID-19 Vaccination Mandates 
for Healthcare Workers
As of February 2021, the Food and 
Drug Administration (FDA) has 
authorized three COVID-19 vaccines 
for emergency use. Data show that 
these vaccines are extremely safe 
and effective at reducing the severity 
of COVID-19. Healthcare workers 
(HCW)—including doctors, nurses, 
trainees, and nonclinical essential 
workers—were prioritized for vac-
cine distribution because of the 
occupational risk they bear in fight-
ing the pandemic. Although the sup-
ply of vaccines is still limited, many 
HCW have already been vaccinated.
However, some HCW have declined 
COVID-19 vaccination. Even before 
COVID, HCW were among the most 
hesitant populations towards occupa-
tional vaccines, such as the seasonal 
influenza vaccine. Insufficient knowl-
edge and understanding of vaccines, 
including concerns about side effects 
and doubts about effectiveness, are 
cited as reasons for hesitancy among 
HCW. (Loulergue et al., 2009) How-
ever, vaccine hesitancy among HCW 
is a matter of public health because 
HCW are disproportionately exposed 
to immunocompromised patients, the 
elderly, and children in their work-
place and therefore have a higher risk 
of transmitting or contracting com-
municable diseases. HCW are also 
key connectors of information for the 
public and have been shown to sway 
patients’ vaccination behavior.
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The information in this newsletter
is not intended to provide legal 
advice or opinions and should not 
be acted upon without consulting an 
attorney.
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In response to this hesitancy to-
wards the COVID-19 vaccine, 
many hospitals and other health-
care organizations are considering 
whether to mandate or require 
COVID-19 vaccinations for their 
employees. Employer-based man-
dates should be assessed both 
legally and ethically. 
There are significant ethical and 
legal concerns about mandating a 
vaccine that is still under an Emer-
gency Use Authorization (EUA). 
The EUA statute does not spe-
cifically prevent employers from 
mandating vaccines that have only 
EUA status. (21 U.S.C. § 360bbb-
3.) However, under the EUA stat-
ute, certain conditions must be met 
before a vaccine is administered. 
Those who receive the vaccine 
must be informed that it has been 
authorized for emergency use, and 
the “known and potential” ben-
efits and risks must be explained. 
Moreover, those receiving the 
vaccine must be informed that they 
have “the option to accept or refuse 
administration,” as well as of “the 
consequences, if any, of refusing 
administration.”
There is uncertainty about whether 
“consequences” of refusing vacci-
nation may include adverse em-
ployment actions, including termi-
nation or reassignment. However, 
in the context of the statute, it is 
likely that “consequences” refers 
to health-related consequences 
only, and that all persons to whom 
the vaccine is administered must 
be given the “option to accept or 
refuse” without threat of repercus-
sions. On the other hand, the statu-
tory requirements likely apply only 
to the entity that actually adminis-
ters the EUA vaccine, which may 
not be the employer. If an employer 
requires its employees to get the 
COVID vaccine from a third 
party—e.g., from a city or county 
vaccination site—then presumably 
the employer would not be subject 
to the statutory requirements.
Nevertheless, the spirit of the EUA 
statute suggests a commitment to 
voluntariness that militates against 
an employer vaccine mandate prior 
to the FDA’s full approval of the 
vaccine. After all, some COVID-19 
vaccines that are currently avail-
able are the first to utilize the new 
mRNA-based technology. So long 
as there remains significant uncer-
tainty about the risks of the vac-
cines, mandates seem difficult to 
justify. 
It is likely that some COVID-19 
vaccines will soon be granted a 
full Biologics License Application 
(BLA) approval by the FDA. Cur-
rent federal law generally allows 
employers to mandate vaccines 
as a condition of employment, so 
long as they comply with laws 
prohibiting employment discrimi-
nation. (Rothstein, Parmet, and 
Reiss 2021) Ethical considerations 
suggest that employers allow broad 
accommodations for people with 
medical, religious, and perhaps 
even moral concerns, even if they 
are not always legally required to 
do so. 
The Americans with Disabilities 
Act (ADA) requires that employers 
provide reasonable accommodation 
to an employee or job applicant 
with a disability, unless doing so 
would pose an “undue hardship” 
i.e., a significant difficulty or ex-
pense for the employer. Under the 
ADA, a “disability” is defined as “a 
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physical or mental condition that 
substantially limits a major life 
activity.” (42 U.S.C. § 12102(2)
(A)-(C).) 
Courts have generally been skep-
tical that a vaccine allergy is a 
disability under the ADA. For 
example, a federal district court 
in Maryland denied an ADA 
claim brought by a medical as-
sistant who had a known allergy 
to a component of the flu vaccine, 
and who requested, but was not 
granted, an exemption from the 
vaccine mandate imposed by her 
employer, a major medical cen-
ter. (Eubanks v. Mercy Med. Ctr., 
Inc. (D. Md. Dec. 17, 2015).) The 
court did not accept the plaintiff’s 
argument that “the functions of 
[her] immune system” constituted 
a “major life activity,” and deter-
mined that her allergies did not 
qualify as a disability under the 
ADA. The court rejected the plain-
tiff’s claim under Maryland’s Fair 
Employment Practices Act (FEPA) 
on the same grounds. (Md. Code 
Ann., State Gov't § 20-601(b)(1).)
This example suggests that the 
conceptual framework of the ADA 
is not well suited to vaccination 
policies. The mere risk of suffer-
ing a vaccine-related injury, no 
matter how great the risk or severe 
the injury, does not itself impair a 
major life activity. Such impair-
ment typically occurs only after 
the vaccine has been administered 
and the injury suffered, but then 
an exemption is of no avail. As an 
ethical matter, therefore, employ-
ers ought not rely solely on the 
requirements of the ADA, but 
should craft a medical exemptions 
policy that allows for exemptions 
even when the underlying medical 
condition would not qualify as a 
“disability” under the ADA.
Americans are much less likely 
to trust the healthcare system and 
express willingness to get vacci-
nated against COVID-19. (Egede 
and Walker, 2020) Much of this 
distrust of Black Americans in 
medicine is rooted in a history of 
oppression, exclusion, and exploi-
tation evidenced throughout U.S. 
history, and specifically within 
American medicine. (Jones, 2021)
For this reason, imposing a vac-
cine mandate on HCW could 
disproportionately affect Black 
HCW, a group that is already un-
derrepresented among doctors, and 
in some contexts overrepresented 
among non-clinical essential staff, 
such as janitors and culinary staff, 
who are likely to be much lower 
paid and perceived by managers 
as easier to replace. (Gaynor and 
Wilson, 2020)
Moreover, if members of racial 
minority groups disproportionately 
refuse to comply with a strict vac-
cine mandate, and suffer adverse 
employment consequences as 
a result, their employer may be 
liable for race discrimination 
under Title VII. In particular, an 
employer’s policy that results 
in a disproportionate number of 
adverse employment outcomes 
for members of a certain racial or 
ethnic group raises a question of 
disparate impact discrimination, 
even if the policy is race-neutral 
on its face. (Cf. Griggs v. Duke 
Power Co., 401 U.S. 42 4, 91 S. 
Ct. 849 (1971).) 
A mandate that disproportionately 
impacts Black Americans and 
other minority and underrepresent-
ed populations is ethically prob-
lematic whether or not it succeeds 
Title VII of the Civil Rights Act 
of 1964 prohibits employers from 
discriminating against employ-
ees on the basis of their religious 
beliefs or practices, and requires 
employers to accommodate these 
beliefs and practices so long as 
the accommodation does not 
impose an “undue hardship, i.e., 
something 'more than a minimal 
burden’ on the operation of the 
employer’s business.” (29 CFR § 
1605.2.) For example, offering to 
transfer an employee who objects 
to vaccines on religious grounds 
to a different organizational role is 
likely a sufficient accommodation, 
even if the employee is unhappy 
with this change. 
The Equal Employment Opportu-
nity Commission (EEOC), which 
administers Title VII, defines 
“religion” very broadly to include 
beliefs and practices that are not 
part of a traditional church or sect. 
However, the category of religious 
belief does not include personal 
preferences, political views, or 
beliefs about science or medicine. 
For example, the belief that vac-
cines “may do more harm than 
good” is a medical, not a reli-
gious belief. The EEOC definition 
correctly reflects the important 
autonomy interest that individuals 
have in being able to live accord-
ing to their sincerely held religious 
or non-religious moral beliefs.
Finally, healthcare organizations 
should consider the disproportion-
ate impact that a vaccine mandate 
may have on HCW who are mem-
bers of a minority racial or ethnic 
group. Data suggest that Black
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in encouraging greater vaccine uptake. If it does succeed, the success could be tainted by the same race-based 
coercion, paternalism, and exploitation that has long haunted American medicine. If HCW from minority groups 
choose to refuse vaccination, however, and disproportionately lose their jobs as a result, then the mandate prob-
lematically contributes to unjust inequities in employment opportunity. 
In conclusion, vaccine hesitancy raises the question of how best to promote COVID-19 vaccine uptake among 
HCW. Strict mandates, however, without adequate opportunities to opt-out, are difficult to justify. Vaccine 
mandates ought always to be considered a “last resort” intervention when combatting low vaccine uptake rates, 
and should be carefully evaluated before implementation. Employer mandates face an even greater justificatory 
hurdle than government mandates, as they are less effective at promoting public health goals such as herd im-
munity.
When considering vaccine mandates, employers must consult the law, but they should not assume that whatever 
is not legally forbidden is therefore ethically permitted. Existing legal constraints sometimes inadequately reflect 
the ethical considerations that apply to employer vaccine policies. (Parmet, 2018) Before imposing a mandate, 
employers should consider alternatives such as masking, testing, and discouraging “presenteeism,” i.e., com-
ing to work while ill. (Edmond, 2019) Employers should also seek to build voluntary buy-in and understanding, 
particularly in light of equity concerns, through clear communication and honest engagement with all members 
of the workplace community. The safest course, both ethically and legally, is to protect patients and workers 
and effectively reduce workplace transmission through all means possible before considering and implementing 
mandates.
Brian Hutler, JD, PhD and Rachel Gur-Arie, PhD 
Hecht-Levi Postdoctoral Fellows
Berman Institute of Bioethics 
Johns Hopkins University
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A Conversation about Vaccine Mandates: 
MHECN COVID-19 Working Group 
An infectious disease physician 
at a Montgomery County hospital 
introduced the topic of whether 
it is ethically justified to mandate 
COVID vaccines for healthcare 
staff after the vaccines are FDA-
approved. At his hospital there 
has been ~70% staff vaccine ac-
ceptance. Patients have already 
asked if staff caring for them have 
been vaccinated for COVID and 
if not, some have requested to be 
transferred to the care of another 
provider. One can foresee hospi-
tals advertising based on employee 
vaccination rates, making this a 
marketing tool, not just a public 
health measure. He asked for the 
Working Group’s (WG’s) thoughts 
on the following questions: 
Does information regarding vac-
cine refusal/acceptance pose a 
breach of privacy/confidentiality?
There is a question of whether 
information about employees’ 
COVID-19 vaccination status is 
maintained on behalf of the em-
ployee health plan and thus cov-
ered by HIPAA’s privacy require-
ments. Even if this were true, a 
waiver could be issued by the 
employee.
Are vaccine mandates more effec-
tive than persuasion or incentives 
(e.g., paid sick leave)? 
The WG discussed concerns about 
the efficacy of a vaccine mandate. 
For example, it was suggested that 
flu vaccine mandates for health-
care facility staff have not been 
shown to produce the expected 
outcomes of reducing patient 
morbidity/mortality. Taking into 
account that we do not currently 
know to what extent COVID 
vaccination itself reduces trans-
mission, this may be relevant (a 
presumed benefit of a vaccinated 
worker is that he/she is less likely 
to infect patients/visitors). In addi-
tion, a mandate could disincentiv-
ize employers from engaging with 
staff to hear their perspectives and 
earn their trust, which could widen 
gaps in trust that are essential for 
public health goals to be achieved.
Do vaccine mandates discriminate 
disproportionately against mar-
ginalized communities? 
Given that there are higher rates of 
vaccine refusal among communi-
ties of color, and persons of color 
are overrepresented in certain 
healthcare sectors (e.g., long-term 
care and ancillary hospital staff-
ing), a mandate could dispropor-
tionately affect this already mar-
ginalized population by restricting 
job opportunities for those who 
prefer to avoid vaccination.
 
Is there a difference between 
mandating vaccination for current 
staff versus new hires? 
Given that newly hired staff could 
be told about the vaccine man-
date and choose not to take the 
job, some may see a difference 
between mandating the vaccine 
for current staff versus new staff, 
since the latter would have 
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received “notice.” However, 
whether one is deprived of getting 
a job or of losing a current job 
may not be an appreciable distinc-
tion.
Is reduced employee absenteeism 
a sufficient reason for a mandate?
Even if vaccinating staff doesn’t 
reduce patient contagion, there 
is clearly a benefit in reducing 
employee absenteeism due to 
sickness. Reduced transmission is 
also likely (though not yet dem-
onstrated), and preventing hospi-
talizations and serious illness of 
healthcare workers and those who 
are immunocompromised (e.g., 
bone marrow transplant patients, 
NICU babies) is an appreciable 
benefit, as gaps in COVID protec-
tion can be fatal. 
Are there valid contraindications 
to COVID vaccine? 
One physician reported that at his 
hospital, for flu vaccine, which 
is mandated for staff unless a 
request is made based on health 
exemptions, about 1% of staff 
have a valid contraindication. This 
is expected to be quite rare for 
COVID vaccine. Anaphylaxis is 
very low. A lawyer-ethicist offered 
that the only appreciable risk at 
the population level (for staff) is 
dignitary and emotional, that is, 
taking away a worker’s choice to 
refuse the vaccine (for whatever 
reason). They get the benefit of 
being spared from serious illness/
death, protection from symptom-
atic illness, and most likely not 
being a vector within their own 
household. 
Is a COVID vaccine mandate ethi-
cally justified?
The consensus of the group is that 
there is more benefit from ensur-
ing that all staff are vaccinated 
and although the answer to “can a 
vaccine mandate be implemented” 
is “yes,” the question of “should a 
vaccine mandate be implemented” 
needs to be considered from all 
angles. It is comparable to the 
flu vaccine mandate. Is there an 
opt-out for anyone? Will staff 
declining vaccination be stigma-
tized? Isn’t it ethically preferable 
to engage staff and try to get their 
buy-in?
A hospital chaplain noted that we 
all live in a community, and there 
are inevitable conflicts between 
respect for autonomy and promot-
ing the common good; there are 
times autonomy can be justifiably 
overridden. While the harm is not 
trivial, it can be reduced if people 
feel like they have been heard/
respected enough for that conver-
sation to be had by them or people 
who look like them. Of note, 
no religious body has come out 
against COVID vaccines. 
An emergency planning expert 
noted that in previous epidemics 
(e.g., Ebola, HIV/AIDS) there 
were similar concerns; everyone 
has an opinion (s)he should not 
be afraid to voice. Leadership has 
learned they need to gather those 
opinions to form a marketing 
campaign to support their deci-
sions. Based on what we know so 
far, there will be a lot of people 
refusing a vaccine. It is not clear 
whether, even when supply is 
adequate, we will reach herd im-
munity. Healthcare is one of the 
few sectors that will be put out in 
front of this to make this decision. 
Which groups will be mandated to 
get vaccinated? Teachers, health-
care workers, airline employees       
(i.e., those in unavoidable close 
proximity to those they serve)? 
A physician echoed the need to 
have conversations at the C-suite 
level to achieve procedural justice, 
and to include diverse representa-
tion in these conversations. She 
underscored that how administra-
tors do this matters; a mandate 
may be OK but that doesn’t 
absolve leaders from talking with 
rather than at employees. 
A law professor suggested that 
the word “mandate” is negatively 
laden and might be replaced with 
another term. However, another 
lawyer in the group warned of the 
dangers of euphemisms, and that 
honesty is important. 
A physician mentioned that her 
hospital was reluctant to im-
pose vaccination with the threat 
of termination. However, many 
companies and healthcare facili-
ties appear to be moving toward 
mandates. 
The WG agreed vaccination must 
be part of a multi-prong strategy, 
and that a variety of individuals 
should be at the table when decid-
ing whether it should be manda-
tory, from janitors and kitchen 
workers to nurses and physicians. 
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COVID-19 Vaccine Ethics Forum Focuses on 
Interprofessionalism, Equity, and Faith
On November 10, 2020, MHECN 
co-sponsored the Seventh Annual 
Interprofessional Forum on 
Ethics and Religion in Health 
Care: Unraveling Vaccine Science, 
Faith, and Public Discourse. Vac-
cine researcher and University of 
Maryland (UMB) School of Medi-
cine faculty Dr. Matthew Laurens 
gave an overview of COVID-19 
vaccines being tested in clinical 
trials. 
Deanna Tran, with the UMB 
School of Pharmacy, reviewed 
causes of “vaccine hesitancy,” 
mostly resulting from misinfor-
mation and myths, for example, 
that vaccines cause autism or 
overload the body’s immune 
defenses (science has debunked 
both positions). Dr. Tran called 
for a multidisciplinary approach 
to overcome vaccine hesitancy by 
role modeling vaccine adoption 
and using motivational interview-
ing techniques and outreach efforts 
to educate patients and the public 
about vaccine efficacy and safety. 
Trudy Henson, Public Health 
Program Director at the Center 
for Health and Homeland Security 
and an adjunct professor at UMB’s 
Carey School of Law, reviewed 
the law and policy considerations 
for COVID-19 vaccines that 
become available, such as how 
to fairly allocate vaccines that 
are in short supply, and whether 
mandating vaccination would be 
justified or effective. She provided 
background information on exist-
ing public health powers, such 
as those articulated in the 1905 
Supreme Court case Jacobson v. 
Massachusetts, while emphasiz-
ing that vaccine mandates might 
not be the only or most effective 
policy approach. While highlight-
ing the importance of promoting 
vaccination through encourage-
ment and example, Henson also 
spoke on the potential pitfalls 
of strongly encouraging or even 
mandating vaccinations should 
demand exceed supply, which 
occurred with the H1N1 vaccine 
in 2009. Responding to questions 
after her presentation, she also 
discussed the likelihood of vac-
cination becoming a condition of 
employment for some frontline 
healthcare workers, explaining 
that while such requirements were 
likely to be permissible, especially 
for private employers, those man-
dates were likely to be delayed 
due to questions of supply.
Yolonda Wilson, Fellow with 
the National Humanities Center 
and Encore Public Voices, ad-
dressed how systemic racism has 
harmed—and continues to harm—
Black and Brown people by way 
of their being more susceptible to 
suffering serious and fatal
COVID-19 disease and hav-
ing poorer access to COVID-19 
research, testing, treatment, and 
vaccination opportunities. For 
example, researchers may simply 
assume that Black people don’t 
trust science and won’t volunteer 
for research trials, rather than 
enlisting their feedback about how 
to gain their trust and cooperation. 
Ken Berkowitz, Special Advisor 
with the Veterans Health Admin-
istration’s National Center for 
Ethics in Health Care, reviewed 
data showing that healthcare facil-
ity flu vaccine mandates for staff 
have not achieved better outcomes 
compared to voluntary flu vaccina-
tion. Given that vaccination rates 
are lower among persons of color, 
this raises the question of whether 
vaccine mandates unfairly disad-
vantage persons of color. Individ-
ual liberty should be preserved if 
persuasion can effectively promote 
trust that vaccines are in an indi-
vidual’s best interest and that of 
their community.
Rabbi Shmuel Silber of Suburban 
Orthodox Toras Chaim offered a 
Jewish interpretation of the ten-
sion between faith and science. 
God has control over everything – 
both the pandemic and the science 
that creates remedies to cure and 
eradicate disease. When there is 
tension between the needs of the 
community and the individual, the 
community always wins out. This 
is a view focused on individual 
responsibilities to create a society 
that benefits every individual. If 
a vaccine is found to be safe and 
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effective, there is an obligation to 
take the vaccine. The overwhelm-
ing majority in the Jewish com-
munity are “pro-vaccine” for this 
reason. A Jewish approach to vac-
cine allocation would use a similar 
calculus to identify what is best 
for the community (for example, 
prioritizing frontline healthcare 
workers who are in the greatest 
danger and who can preserve oth-
ers’ well-being). 
Bowyer Freeman, Senior Pastor 
at New St. Mark Baptist Church, 
proposed that science and religion 
work together to help us better 
understand our human nature. 
Pastor Freeman’s background 
in genomics gives him a unique 
perspective on this issue. For ex-
ample, new genetic advances may 
benefit some and exacerbate social 
disparities for others. In order for 
COVID-19 vaccine science to 
benefit all, it must be adopted by 
the majority to achieve the goal 
of herd immunity. Trust is key. In-
deed, pastoral care, clinical ethics, 
and medicine require a foundation 
of trust.  Pastor Freeman referred 
to this as “trust economics,” a 
term not intuitively aligned with 
religion. However, considering 
that “economics” involves the 
production, consumption, and 
transfer of wealth, a spiritually-
informed approach recognizes that 
wealth and health are intertwined, 
and that when large portions of 
the community are left behind, 
societal wealth is elusive. This is 
something we have seen first-hand 
during the COVID-19 pandemic.
Anita J. Tarzian, PhD, RN 
MHECN Program Advisor
The recording and slides of the November 10 forum are available on MHECN’s website, 
under Workshops and Conferences.
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Allocating Scarce Medical Resources at Hospitals in Maryland 
In response to the COVID-19 
pandemic and the possibility of re-
source shortages, Maryland’s five 
largest health systems (The Johns 
Hopkins Health System, the Uni-
versity of Maryland Medical Sys-
tem, MedStar Health, LifeBridge 
Health, and Luminis Health) 
partnered to develop guidelines 
and processes for the allocation 
of scarce resources (ASR). These 
five hospital systems, or the “5H,” 
engaged with multi-disciplinary 
working groups to recommend 
a series of factors that should be 
considered in deciding who should 
receive scarce resources during a 
pandemic such as COVID-19. The 
resulting draft framework, pub-
lished as “Operational Recommen-
dations for Scarce Resource Al-
location in a Public Health Crisis” 
and referred to herein as the 5H 
ASR Framework, seeks to enhance 
survival and maximize treatment 
benefits for as many patients as 
possible when resources are scarce 
while prioritizing ethical consid-
erations. The 5H ASR Framework 
includes triage plans for eight 
scarce resources: ventilators, blood 
products, ICU beds, ECMO, dialy-
sis, convalescent plasma, remdesi-
vir, and hydroxychloroquine. 
Acknowledging that the 
COVID-19 pandemic is not over 
and that future pandemics are 
possible, the Maryland Health-
care Ethics Committee Network 
(MHECN) has worked with 
representatives of the five health-
care systems to make the 5H ASR 
Framework available to Maryland 
hospitals and the public. The pur-
pose of dissemination is to make 
the community aware of choices 
that would be made by hospitals 
if these medical resources were in 
short supply. 
In February 2021, MHECN’s 
COVID-19 Working Group col-
lected feedback on the 5H ASR 
Framework from MHECN mem-
bers (including healthcare ethics 
committee members) and contacts 
through its listserv and encouraged 
broader dissemination. MHECN 
received twenty-one responses, 
reflecting a wide variety of health-
care professions including physi-
cians, clinical ethicists, social 
workers, and palliative care pro-
viders. Approximately eighty per-
cent of respondents were familiar 
with ASR frameworks, nationally, 
for pandemic triage during crisis 
situations. However, respondents 
were far less familiar with the 5H 
ASR Framework and the 2017 
proposed ASR framework which 
the current 5H ASR draft is based 
on. Of the scarce resources includ-
ed in the 5H ASR Framework and 
in the survey, survey respondents 
had the highest familiarity with 
ventilator allocation. The high 
familiarity with ventilator triage 
plans was expected since mechani-
cal ventilators were identified as 
a possible scarce resource early in 
the pandemic.
Since the 5H ASR Framework 
is based on distributive justice 
with equitable and standardized 
practices, fairness in triage de-
cisions is critical. When asked 
which components of the 5H ASR 
Framework are the most critical 
for ensuring fairness in ASR triage 
decisions, respondents identified 
the availability of palliative care 
and hospice services for patients 
not eligible for limited lifesav-
ing resources as a top concern. 
Respondents also indicated the 
importance of clear communica-
tion between healthcare providers 
and patients and their families 
about the ASR process. Another 
primary concern was avoiding 
biased decision-making based on 
age, race, or disability. 
Looking towards implementation, 
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respondents were somewhat confident that limited life-saving resource decisions would be fair if Maryland 
hospitals use the 5H ASR Framework during the pandemic under crisis standards of care. Although respondents 
appeared optimistic, there were underlying concerns that decisions would still be biased even if the 5H ASR 
Framework is followed. One respondent stated that “there may be clinicians who figure out how to bypass the 
framework.” Another stated that “[m]ost people will try to do their best to be fair, [but] there will be some prob-
lems in achieving this completely.” Respondents expressed concerns about the successful implementation of the 
framework in the chaotic emergency room setting where there may not be sufficient time for review, stating that 
“[t]he use of a framework will be very important to avoid ad hoc decision making, which is known to be more 
biased.”
Numerous comments addressed the need for a clear anti-discrimination statement in the draft to emphasize 
that allocation decisions should not be based on age, disability or quality of life and life-cycle concerns. One 
respondent commented that “decisions should be made on objective, evidence-based predictions on survival to 
discharge and no decisions should be made based on the patient’s perceived quality of life.” Apprehension that 
people with disabilities may be disfavored under the framework has been a longstanding point of concern for 
various stakeholders, as even neutral language meant to avoid discrimination can produce disparate outcomes. 
MHECN’s Working Group believes it is important to continue public engagement and incorporate stakeholder 
concerns as the 5H ASR Framework circulates among Maryland hospitals. The MHECN survey provided eluci-
dating insights into the health community’s familiarity and views of the 5H ASR Framework. MHECN hopes to 
continue to seek out stakeholder input and concerns from the general public. It would be useful to better under-
stand the public’s familiarity and perspectives on resource allocation for both community input and transparen-
cy in potentially difficult resource allocation decisions. No ASR framework will be perfect, but MHECN seeks 
to provide feedback to the 5H drafters that includes different perspectives and responds to community priorities 
to further ethical principles of justice, transparency, participation, and accountability. 
The proposed ASR framework and related documents are available on MHECN’s website.
Stephanie Vangellow, MPH and
Rob Stenzel, MBE 
JD Candidates
University of Maryland 
Francis King Carey School of Law
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an 
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit 
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others 
in the case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to 
identify the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be 
sent to MHECN@law.umaryland.edu.
CASE PRESENTATION
CASE STUDY FROM A MARYLAND HOSPITAL
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Baby L, an infant of about 24 
weeks gestation, is delivered 
precipitously en route from the 
emergency room to the Labor and 
Delivery suite. The infant has poor 
respiratory effort and is bradycard-
ic to 60 bpm. She is stimulated 
and mask-bagged. She is intubated 
shortly after birth and transferred 
to the NICU after being briefly 
shown to her mother.
The father is called and imme-
diately came to the hospital to 
see his newborn infant. Updates 
are provided to the mother who 
remains in the Labor and Delivery 
suite. 
The parents are both devout Jeho-
vah’s Witnesses. Because of their 
faith, they are adamant that Baby 
L not receive any blood products. 
The mom tells one nurse: “If you 
give her blood, I will not take her 
home with me.”
Although most of the mother’s 
family lives in Africa, she has 
strong social support from other 
family members who live nearby. 
A patient advocate affiliated with 
the Jehovah’s Witness community 
also provides support for the mom 
at the hospital.
At 24 hours of age, the infant 
remains critically ill but fairly 
stable. She is active and alert, her 
labs are not suggestive of infec-
tion, her perfusion and color are 
good, but she remains on respi-
ratory support. The staff remain 
cautiously optimistic about the 
baby’s prospects. However, the 
parents’ refusal of blood products 
quickly becomes a worry, as staff 
anticipate the clinical trajectory of 
the infant and her associated need 
for blood transfusions. Wanting 
to draw upon every supportive 
resource to help give the baby a 
fighting chance, the baby’s prima-
ry nurse requests an ethics consult. 
She, in collaboration with the 
NICU team, wants to be proactive, 
avoid last-minute scrambling, and 
explore every conceivable remedy. 
She wants to know if the health-
care team would be able to give 
the infant a blood transfusion if 
necessary to save her life or avoid 
serious health problems. 
How should the ethicist or ethics 
committee respond?
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Comments from a Neonatologist/Bioethicist
Advances in neonatal medicine 
continue to improve the survival 
of infants with severe medical 
conditions, including infants born 
extremely premature.  Yet the 
morbidity and mortality related 
to extreme prematurity are sub-
stantial in the United States and 
similar countries with inten-
sive neonatal care. Data from 
the National Institute of Child 
Health and Human Development 
(NICHD) suggest that for infants 
born at 24 weeks the average 
survival is 50%.  Among infants 
who survive to 18 months of age, 
one-third to one-half have moder-
ate to severe neurodevelopmental 
impairment. (1)
The infant in this case has several 
additional risk factors. The gesta-
tional age seems uncertain (“about 
24 weeks”) which is crucial; if for 
instance her gestational age is re-
ally closer to 23 weeks, the aver-
age survival decreases to 30% and 
as many as 80% of survivors have 
moderate to severe neurodevelop-
mental impairment. (1) The cause 
for premature labor in this case is 
not disclosed to us, but one of the 
most common triggers is infec-
tion. Infection will increase both 
neonatal morbidity and mortality; 
we are told the infant’s labs and 
clinical status are reassuring for 
no infection, but the infant was 
just born 24 hours ago. Another 
concern is that this infant was 
presumably born outside the hos-
pital with delayed admission to an 
ICU. Rarely do Emergency Medi-
cal Technicians who respond to 
911 calls have the equipment and 
training needed to resuscitate an 
extremely premature infant. The 
resulting hypothermia, inadequate 
oxygenation and ventilation, hypo-
tension and infection exposure all 
increase morbidity and mortality. 
(2) For example, we are told that 
the initial infant heart rate was 
~60, often a trigger for neonatal 
CPR, but are not told if CPR was 
performed.
It is with the above factors in mind 
that we must interpret the clini-
cians’ “cautious optimism” that 
this infant will do well.  Clinicians 
are poor at determining prognosis 
for individual premature infants. 
(3) Key to this case are the odds of 
anemia and severe thrombocyto-
penia.  As many as 80% of prema-
ture infants get red cell transfu-
sions.  Their anemia results from 
immature and impaired erythro-
poiesis and frequent blood draws, 
in addition to the common com-
plications of sepsis, bleeding, and 
need for surgery. (4)  Over 60% 
of premature infants get platelet 
transfusions for severe thrombo-
cytopenia which, if untreated, can 
lead to intracranial hemorrhage 
and further neurologic insult. (5) 
While the need for transfusion is 
common in extremely premature 
infants, there are data to suggest 
that overzealous transfusion may 
also be associated with intraven-
tricular hemorrhage, necrotizing 
enterocolitis, and retinopathy of 
prematurity. (6) Ongoing research 
is focused on determining optimal 
thresholds for transfusions for 
these infants. (7) 
In this case, the religious beliefs of 
the infant’s parents raise the ques-
tion of whether it is possible, and 
of value to the infant, to avoid all 
transfusions. Jehovah’s Witnesses 
believe that the Bible forbids tak-
ing of blood and that those who do 
will be shunned from the com-
munity and endanger their souls. 
(8) The parents here indicate that 
they will abandon the infant if she 
receives a transfusion.
While adults generally have au-
tonomy to make decisions about 
refusing life-sustaining therapies 
for themselves, parents cannot 
always make similar decisions for 
their children. Parent decision-
making neither falls squarely 
within the concept of autonomy 
nor surrogate decision-making.  
The principle of “best interests” is 
often applied to parent decision-
making for children, others use the 
guidepost of “avoiding harm.” The 
ethical and legal latitude given to 
parents who refuse treatments for 
a child often hinge on whether the 
treatments are emergent. If emer-
gent, the child’s interests generally 
prevail, and physical/physiologic 
interests are given greater value 
than spiritual interests. 
We are told that the medical team 
is acting to avoid such an emer-
gent situation, asking the ethics 
consultants to assist with aligning 
the parent and medical team goals. 
Medically, there are several proac-
tive approaches that may minimize 
transfusion need. Clinicians can 
pay meticulous attention to wheth-
er a lab needs to be drawn from 
the infant, optimizing her blood 
volume. There are data to suggest 
that transfusion protocols may 
reduce the use of blood products 
by standardizing lab orders and 
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thresholds for responding to anemia. (9) Intravenous iron can be added.  Studies of erythropoietin have mixed 
results for extremely premature infants but could be considered, if the locally-available formulation is accept-
able to the parents.  There are fewer options to proactively manage severe thrombocytopenia. Treatment with 
recombinant factors would be possible, though the limited data in this population raises concerns for unproven/ 
experimental therapy in a very vulnerable patient. Some medical centers have expertise in “bloodless” medicine 
and surgery and could be consulted for additional strategies; again, relevant data is limited for extremely pre-
mature infants. The Jehovah’s Witness website offers other supports for clinicians seeking blood-conservation 
strategies for Jehovah’s Witnesses.
These proactive medical strategies should be paired with proactive ethical and legal strategies.  The team must 
gather information about this particular family’s beliefs regarding specific blood products—not all Jehovah’s 
Witnesses have exactly the same beliefs.  It is unclear in the above case whether the parent(s) are also from an-
other country; if so, the interplay of religious and cultural beliefs deserves exploration. It is important to explore 
whether these parents believe that their religious culpability is averted if the clinicians actively override the par-
ents’ wishes and transfuse the infant based on medical necessity.  If this is consistent with with their beliefs, this, 
in combination with meticulous efforts to minimize transfusion need, may be an agreeable common ground. The 
family may need reassurances of confidentiality to minimize risk of censure by their community. Many hospitals 
have a Jehovah’s Witness liaison to assist clinicians and families in these scenarios.
When common ground cannot be found, clinicians need to know whether their state has relevant legal cases/ 
statutes relevant to transfusion practices for Jehovah’s Witnesses, particularly for cases involving sick minors. 
(10) Some states may allow physicians to override parent refusal of transfusion in emergencies; some may 
protect physicians from liability if they accede to parent refusal of transfusion.  Some hospitals may encourage 
seeking a second opinion and then transfer to a center willing to follow the parents’ wishes.  It should be noted 
that the transfer of an extremely premature infant at 24 hours of age risks additional morbidity/mortality, so this 
option for this infant would need to be considered very carefully.
Renee Boss, MD, MPH
Associate Professor, Rembrandt Foundation 
Professor of Pediatric Palliative Care
Associate Professor of Pediatrics
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Comments from a Healthcare Attorney
We are presented with the case 
of an infant of 24 weeks’ gesta-
tion.  Her parents are described as 
devout Jehovah’s Witnesses who 
are opposed to blood transfusions.  
Baby L is critically ill but fairly 
stable after birth, and the ethics 
committee has been asked by the 
baby’s nurse to consult on the 
baby’s care in order to avoid last-
minute scrambling.
It is critical to note that, at “about” 
24 weeks’ gestation, Baby L is in 
the “periviable” window.   Any 
infant of 24 weeks’ gestation has 
a number of critical care deci-
sions that need to be made, of 
which the transfusion issue is only 
one aspect.  Baby L is within the 
window when a number of infants 
do not survive or only survive but 
with significant and permanent 
limitations, even if they do receive 
transfusions.
I would recommend that a social 
worker first talk to the parents to 
learn more about their values, pri-
orities, religious beliefs, cultural 
values, family or religious com-
munity pressure, and understand-
ing of their daughter’s clinical 
situation.  The person meeting 
with the parents should know that 
Jehovah’s Witnesses are generally 
supportive of modern medicine, 
except for the transfusion issues.  
The person should also be aware 
that different Witnesses have dif-
fering interpretations of the prohi-
bition on blood transfusions—for 
example, some Witnesses allow 
the transfusions of plasma but not 
whole blood, while others prohibit 
all blood products.  Social work-
ers are often better at interview-
ing patients than busy members 
of the care team, who can make 
parents feel defensive or pushed, 
sometimes causing them to be-
come more adamant.  If possible, 
it could be helpful to interview 
the parents separately to allow for 
candid one-on-one communica-
tions, as sometimes one parent 
may be afraid to state his or her 
own views or to ask questions 
in front of the other. During all 
phases of the treatment process, 
the parents should be provided 
with the best available information 
as to the baby’s clinical situation 
so that they can make the most in-
formed decisions about all aspects 
of the baby’s care, not just those 
pertaining to the transfusion issue.
The American College of Ob-
stetricians and Gynecologists 
(“ACOG”) published a position 
paper in October 2017, called 
the “Obstetric Care Consensus.”  
The ACOG statement describes 
periviable as 20–26 weeks and 
notes that, while a number of fac-
tors can influence viability, it is a 
very complex and ethically chal-
lenging area.  It notes no “bright 
line,” but, rather, gives a range of 
outcomes based on various fac-
tors and analyses.  The statement 
notes that very small differences 
in gestation can materially af-
fect outcomes, i.e., if “about 24 
weeks” is really closer to 23 or 25 
weeks, the clinical outcomes can 
vary significantly.  After reviewing 
various clinical issues, the ACOG 
article discusses the importance 
of family counseling, “giving the 
patient [mother] and her family 
the opportunity to express their 
values and preferences.”  The ar-
ticle talks about the importance of 
interdisciplinary perspectives and 
coordination to ensure consistent 
messaging, including acknowl-
edgement when data are uncertain 
and consensus cannot be obtained.  
“It is important that the healthcare 
team provide accurate, balanced, 
and unbiased information and 
guidance.” (p. e195)  
The ACOG statement also notes 
that, because different provid-
ers may have differing views and 
the treatment teams may vary or 
rotate, “it is preferable that institu-
tions develop consensus guide-
lines regarding counseling about 
outcomes and a general approach 
to resuscitation of the periviable 
newborn... The family should be 
counseled regarding short-term 
and long-term consequences that 
are anticipated in the context of 
evolving clinical findings for their 
newborn...When a decision has 
been made to withhold or with-
draw life-sustaining treatment 
after birth, the newborn should 
receive individualized compas-
sionate care that is directed toward 
providing warmth, minimizing 
discomfort, and allowing the fam-
ily to spend as much time with 
their newborn as desired.”
The consistent theme in the ACOG 
statement is that decisions regard-
ing periviable newborns should 
generally be made by the patient 
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and her family, giving them as 
much support, information and 
time as is reasonably available.
An article published in 2021 from 
the aptly-named “UpToDate.com” 
concurs, noting that “most infants” 
survive over 26 weeks and few 
survive below 22 weeks, so the 
difficult range is 22-26 weeks.  
They note the difficulty in pre-
cisely calculating gestational age 
and the several factors that affect 
survivability within the window.
While the statute relates to abor-
tion rights, Md. Code Ann Health-
Gen. 20-209 uses a medical defini-
tion of viability—that of when the 
attending physician finds, using 
her best medical judgment based 
on the particular case, that there is 
a reasonable likelihood of survival 
outside the womb.
Critical members of the treatment team should also be present so as to 
provide important clinical information.
The meeting should seek to promote dialogue and to problem-solve, 
rather than to push anyone’s agenda or to dissuade the parents from their 
religious beliefs.
It is possible to obtain a court order to override the parents’ wishes as to 
transfusion issues, and I have done so in appropriate occasions when an 
infant would be otherwise viable and may be in need of a transfusion that 
overrides a parents’ religious beliefs. Typically such orders name a hos-
pital administrator as emergency guardian of the person with the limited 
authority to be able to consent to transfusions, are obtained for very short 
windows of time (144 hours), and are sought, whenever possible, with 
appropriate advance notice to the parents and with counsel appointed for 
the infant. They are often scheduled for a subsequent hearing after the 
initial period has expired, but subsequent hearings are often moot.  In 
some cases, the administrator never has to consent to a transfusion, as 
every reasonable effort is made to avoid the transfusion, both for clinical 
reasons and due to the parents’ objections.
We do not know all the facts in this case that would be available in a 
real situation. However, given that Baby L is reportedly in the midst of 
the periviable period, I would counsel the hospital to try to defer to the 
parents’ decision-making, based on as much objective information as 
time and the patient’s situation will allow and a discussion of the parents’ 
beliefs and priorities, so long as the decisions are made within the bound-
aries of the law and Hospital policy.
Sigrid C. Haines
Partner
Whiteford, Taylor & Preston
References:
American College of Obstetricians and Gynecologists; Society for Maternal-Fe-
tal Medicine. Obstetric Care consensus No. 6: Periviable Birth. Obstet Gynecol. 
2017 Oct;130(4):e187-e199. doi: 10.1097/AOG.0000000000002352. Periviable 
birth (Limit of viability). https://www.uptodate.com/contents/periviable-birth-
limit-of-viability.
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Once the parents have been 
interviewed in the most comfort-
able manner possible, they should 
be invited to meet with the eth-
ics committee (or ethicist) in a 
non-confrontational forum for a 
discussion as to how to best care 
for Baby L. Given Baby L’s birth 
within the window of perivi-
ability, the threshold question of 
whether to provide aggressive or 
comfort care should be addressed 
first, aside from the transfusion 
issue.  If the decision is to provide 
aggressive care, additional deci-
sions need to be made, including a 
discussion regarding transfusions.  
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What the Ethicist and Ethics Committee Did
After a chart review, the ethics di-
rector’s first call was to legal and 
then he proceeded to Labor and 
Delivery to meet the mother. They 
talked about the wonder of birth, 
the challenges ahead, her love for 
her infant, and how she wanted 
everything done to save the life of 
her baby; the one exception being 
administering blood products. The 
ethics director asked if she would 
like a visit from one of the hospital 
chaplains to provide spiritual sup-
port. After being assured that the 
ministry would be provided in the 
name of Jesus and Jehovah, she 
gratefully agreed. The ethicist as-
sured the mother that she and her 
infant would receive the best care 
possible and that he would remain 
in regular contact. She smiled and 
expressed her gratitude.
Meanwhile the hospital’s legal 
and risk management offices were 
examining what options might be 
available. There was not an ap-
petite for going to court to try to 
get a judge’s emergency ruling to 
allow the hospital to administer 
blood products. They felt there 
was not sufficient precedent in 
the state of Maryland. Thus the 
initial legal recommendation was 
to invoke the emergency treatment 
section of the Maryland Health 
Care Decisions Act (MHCDA). 
The attorney’s thinking was:  
1) The treatment would be of an 
emergency nature; 2) The people 
authorized to give consent would 
not be immediately available; and, 
3) Without the treatment there 
would be substantial risk of death. 
That approach, however, did not 
resonate with the clinical care 
team as the mom was still a patient 
in Labor and Delivery and the 
father was just a phone call away, 
and it would take a bit of time to 
actually get blood delivered to the 
unit. Of course the parents were 
available for decision-making. In 
response, the ethicist reached out 
to a law professor who was famil-
iar with the MHCDA for a col-
legial discussion and opinion. She 
recommended that we reconsider 
going to court making the argu-
ment that it was an emergency as 
the infant could decompensate at 
any time. This opinion was re-
layed back to the hospital attorney 
and he was asked to reconsider 
his recommendation. When it 
became apparent to legal counsel 
that treating under the auspices of 
the parents being unavailable to 
provide consent was not a viable 
approach, he agreed to explore 
the option of going to court. Risk 
management was going to explore 
options as well, and the ethicist 
was going to engage in another 
conversation with the baby’s 
mother, as they had established a 
warm and trusting relationship.
Meanwhile, the staff continued to 
worry as the infant remained in 
critical condition and they knew 
that the time was approaching 
when blood transfusions would 
be necessary. All involved were 
caring for Baby L not just with 
skill and determination, but with 
kindness and concern.
During a lengthy conversation, the 
baby’s mother once again affirmed 
that blood products were not to be 
used. She and the ethicist openly 
discussed how seriously ill her be-
loved daughter was and that soon 
the physicians would likely be at 
a point where they would need to 
provide blood in order to save the 
life of the child. She was directly 
asked what are we to do when that 
point comes? She replied: “Well 
that would be a decision that YOU 
make.” A door seemed to be open-
ing.  Asked if she would accept 
the doctors’ decisions, she said, 
“Yes.” A preliminary conversation 
then took place about allowing the 
care team to become the medical 
decision-maker regarding what 
treatments would be necessary to 
potentially save the life of Baby 
L. Several follow-up discussions 
were held throughout the morn-
ing and afternoon, and the mother 
affirmed each time that she would 
allow the medical providers to 
make decisions about necessary 
treatments. These discussions 
were documented in the chart.
Next, the Patient Care Advisory 
Committee (PCAC) process was 
explained by the ethicist to the 
mother and she accepted the invi-
tation for herself and her husband 
to attend the meeting. She was 
informed who the participants 
would be: COO as designee of the 
hospital president, SW, physician 
who is not the attending, director 
of risk management, senior nurs-
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ing director, chaplain, and ethics 
director as moderator. She was in-
formed that the recommendations 
of this group would be imple-
mented by the hospital. If she and 
her husband disagreed they would 
have the right to take the matter 
to court and ask a judge to reverse 
the decision or they could seek a 
transfer of the patient.
The process began with a meet-
ing between the care team and the 
PCAC, the purpose of which was 
to discuss the clinical details. The 
consensus recommendation of the 
PCAC was strong and clear: given 
that Baby L was most likely to 
need life-saving transfusions, there 
was a medical necessity for the 
care team to have that treatment 
available to use. The PCAC would 
present that decision to the family.
The PCAC meeting was held with 
Baby L’s parents immediately 
thereafter. Although this situation 
was taking place during a time 
when most meetings were being 
held via Zoom, the PCAC felt that 
face-to-face interaction was essen-
tial. After introductions, the medi-
cal situation was updated for the 
family. They were again informed 
about the baby’s anticipated need 
for blood products.
The Committee members ex-
plained that they had reached a 
consensus that blood products are 
likely to become medically neces-
sary in order to provide optimal 
care for their baby. The parents 
understood the situation and 
indicated that they did not want to 
contest either the decision or the 
treatment plan. They proceeded to 
explicitly ask that the clinical care 
team become the decision-maker, 
not just for blood-related decision-
making but for all treatments. Each stated they trusted that whatever 
decisions were made would be in the best interests of Baby L. They indi-
cated that all they were asking for at this point was to be kept informed 
of what treatments were being provided and to receive regular updates on 
how their daughter was doing.
When the outcome of the meeting was shared on the NICU the relief was 
palpable among the staff.  They were caring for the infant with dedica-
tion, skill, and tenderness, and with some emotional investment. In the 
week to come, Baby L’s medical condition waxed and waned. For the 
most part she remained in critical condition—on respiratory/temperature/
and feeding support, moderately increased heart size with apnea/brady-
cardia/desaturation episodes, and continuing anemia. That said, she also 
remained reassuringly active.
Thirteen days after being born, however, Baby L developed hydrocepha-
lus. Two days later she was transferred to a regional pediatric hospital 
where she remains in critical but stable condition as of this writing. The 
ethics notes, which describe the agreed-upon process for making deci-
sions, especially in regard to blood products, accompanied her.
Comments from the Hospital’s Ethics 
Director
The ethical dilemma is fairly 
straightforward. There is obvi-
ous tension between respecting 
the autonomy of the parents as 
decision-makers and honoring 
their firmly held religious beliefs 
and protecting the welfare of a 
vulnerable, critically-ill infant who 
cannot speak for herself. The care 
team, regularly assured the parents 
that we would always respect their 
faith but that our primary goal was 
to give Baby L the best chance to 
survive and be as healthy as possi-
ble. From very early on, the team, 
with unwavering commitment, 
acted on the moral obligation to be 
a voice for the infant who could 
not advocate for herself, respect-
ing but giving less weight to the 
autonomy of the parents in prefer-
ence to the welfare of the baby. 
In an ironic and parallel fashion 
the parents were also working out 
their own internal moral dilemma. 
They had to grasp two opposing 
pathways at once: live by their 
faith and do the right thing for 
their baby. These were not syn-
chronistic courses of action. As 
the parents were struggling to find 
a way to reconcile the conflicting 
options, they began to see how the 
agreed-upon solution offered them 
a way for bending but not break-
ing their faith while giving their 
daughter the very best chance at 
life. In never having been required 
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to give consent for blood products they would be relieved of some shame and guilt, as well as moral culpability.
Recently, the Senior Nursing Director remarked, as we were discussing Baby L’s current condition at [the 
pediatric hospital], “I hope after she is fully stabilized, she will come back to us. She will get great care at [the 
pediatric facility]. Here she will receive great love.”
A few salient take-home lessons loom large:
•  The all-hands-on-deck approach, which was activated early on, was helpful.
•  Building trust across a cultural divide is essential. This requires time and being mindfully present at the
    bedside.
•  Being creative and relentless in considering options and approaches can be useful.
•  Applied ethics entails rolling up one’s sleeves and engaging with all of the important stakeholders in 
   interdisciplinary collaboration. It extends far beyond philosophical and theoretical approaches to 
   resolving problems.
•  Sometimes love works, even in the high-pressured environment of modern healthcare.
2021 Webinar List
Children’s Mercy Kansas City
Brown Bag Workshops*
Use of Tertiary Care Pediatric Emergency Department for Over-the-Counter Medications  
Tuesday April 27, 2021
Cassandra Newell, MSN, CPNP, RN, CPN, Pediatric Nurse Practitioner, Emergency Department, CMKC
LeChelle Nelson, RN, CPN, MSN, CPNP-BC, Critical Care Nurse Practitioner, 
Emergency Department, CMKC
Rates of Positive Suicide Screens among the Emergency, Inpatient and Outpatient Clinics at a 
Tertiary Care Children’s Hospital
Tuesday May 18, 2021
Fajar Raza, MBBS, Pediatric Ethics Fellow, CMKC
Shayla Sullivant, MD, Child & Adolescent Psychiatrist, CMKC
Do Reasons Matter? Rethinking Pediatric Treatment Disagreements
Tuesday June 22, 2021
Amy Caruso-Brown, MD, MSc, MSCS, Associate Professor of Pediatrics and Bioethics & Humanities, 
SUNY Upstate Medical University, Syracuse, NY 
*All Brown-Bag Workshops take place from Noon – 1PM CDT. For non-employees of Children's Mercy, please 
contact Jeremy Garrett (jgarrett@cmh.edu) and Jennifer Pearl (jepearl@cmh.edu) via email (preferably at least 3 
business days in advance) if interested in attending.
Pediatric Bioethics in the Shadow of COVID Symposium
Wednesday, May 5, 2021 9:00 am CDT
The COVID-19 pandemic raised complicated ethical issues for children and those who care for them. Children’s 
Mercy Bioethics Center will host a symposium to discuss these complex ethical issues. Thought leaders in pediatric 
bioethics and health policy will reflect on the successes, failures and surprises that arose and that likely will continue 
with the COVID-19 pandemic.  Register here.
Columbia University
Racing with Vaccines:  Data, Narratives, and Ethics 
With Robert Klitzman (Bioethics), Danielle Spencer (Narrative Medicine), and David Kreutter (Applied 
Analytics). Watch the recording here.
COVID-19 Related Webinars compiled by the Columbia University Department of Medical Humanities 
and Ethics can be found here.
CALENDAR OF EVENTS
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Hastings Center
Hastings Center President Mildred Solomon was a featured speaker on Included: The Disability 
Equity Podcast of the Johns Hopkins University Disability Health Research Center. Read the transcript 
here.
Advancing Social Justice, Health Equity, and Community. The Daniel Callahan Annual Lecture, with Duke 
professor Patrick Smith and Hastings Center president Mildred Solomon, was held February 9, 2021. Click 
here to watch the Zoom event.  
Johns Hopkins
On the Outrage of Black Mothers: Healing the Past in the Present
Tuesday, Apr 20, 2021, 12:00 - 1:00 pm EST 
Ethics For Lunch
The Many Faces of Trust During the Pandemic: Watch the Video
Ethical Challenges of Effective Pain Management in Patients with Severe Cancer Pain and Substance 
Use Disorder: Watch the Video
University of Maryland Carey School of Law
The Rothenberg Health Care Law & Policy Speaker Series
Challenges in Equitable Allocation of SARS CoV-2 Vaccine
Professor R. Alta Charo, the Warren P. Knowles Professor of Law and Bioethics at the 
University of Wisconsin at Madison.  
Watch the recorded presentation here.
The Politics of Public Health Regulation 
Joshua M. Sharfstein, Vice Dean for Public Health Practice and Community Engagement and Professor of 
the Practice at the Johns Hopkins Bloomberg School of Public Health 
Watch the recorded presentation here.
Eradicating Systemic Racism in the Government's Pandemic Response 
Professor Ruqaiijah Yearby, Executive Director and Co-Founder of the Institute for Healing Justice and 
Equity Center for Health Law Studies and Professor at the Saint Louis University School of Law
Watch the recorded presentation here.
CALENDAR OF EVENTS (cont.)
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Michigan State University Bioethics
Healthcare Artificial Intelligence Needs Patient Data: Who “Owns” the Data About You?
Adam M. Alessio, PhD, Professor, Department of Computational Mathematics, Science, and Engineer-
ing; Department of Biomedical Engineering and Radiology; Institute for Quantitative Health Science & 
Engineering, Michigan State University. 
View Recorded Webinar
Maternity Care Deserts in Rural Michigan
Andrea Wendling, MD, Director of Rural Medicine and Professor of Family Medicine, Michigan State 
University College of Human Medicine.
View Recorded Webinar 
Is Seeking Information on Social Media Harmful to Your Health?
Anjana Susarla, PhD, Professor of Information Systems, Michigan State University Eli Broad College of 
Business.
View Recorded Webinar 
Controversies and Complexities in LGBTQ Health Care
Emily Antoon-Walsh, MD, MA, FAAP (she/her), Seattle Children’s Hospital Regional Pediatric 
Hospitalist; Clinical Assistant Professor, Department of Pediatrics, University of Washington.
Barry DeCoster, PhD (he/him), Associate Professor of Bioethics and Philosophy, Department of  
Population Health Sciences, Albany College of Pharmacy and Health Sciences.
Henry Ng, MD, MPH, FAAP, FACP (he/they), Center for LGBTQ+ Health, Transgender Surgery 
and Medicine Program, Cleveland Clinic Foundation.
View Recorded Webinar 
Washington State University 
"Bioethics Grand Rounds: Health Professional Rights and Obligations During Pandemic"
April 28th, 2021, Noon-1:00pm PST
Matthew Wynia, PhD, MPH & Heidi Malm, PhD
Register Here
CALENDAR OF EVENTS (cont.)
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The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by the Law and 
Healthcare Program at the University of Maryland Francis King Carey School of Law. The purpose of MHECN is to facilitate 
and enhance ethical reflection in all aspects of decision making in health care settings by supporting and providing informational 
and educational resources to ethics committees serving health care institutions in the state of Maryland. The Network attempts to 
achieve this goal by:
• Serving as a resource to ethics committees as they investigate ethical dilemmas within their institution and as they strive to 
assist their institution act consistently with its mission statement;
• Fostering communication and information sharing among Network members;
• Providing educational programs for ethics committee members, other healthcare providers, and members of the general 
public on ethical issues in healthcare; and
• Conducting research to improve the functioning of ethics committees and ultimately the care of patients in Maryland.
MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from affiliate 
members who provide additional financial support.
The Law & Health Care Program
Maryland Healthcare Ethics 
Committee Network
University of Maryland  
Francis King Carey School of Law
500 W. Baltimore Street
Baltimore, MD 21201
SUBSCRIPTION ORDER FORM







No. of Subscriptions Requested:
     Individual Subscriptions     Institutional (MHECN    
     @ $35/yr.        non-member) Subscriptions 
         @ $90/yr.  (up to 20 copies)
Please make checks payable to:  The University of Maryland
and mail to: The University of Maryland School of Law
  Law & Healthcare Program - MHECN
  500 West Baltimore Street
  Baltimore, MD  21201
For information on MHECN membership rates, contact us at 
MHECN@law.umaryland.edu, or (410) 706-4457 or visit http://www.law.umaryland.edu/mhecn
All correspondence  
including articles, cases, 
events, letters should 
be sent to:
Diane E. Hoffmann 
Editor
The Mid-Atlantic Ethics  
Committee Newsletter
University of Maryland
Francis King Carey 
School of Law
L&HCP
500 W. Baltimore Street
Baltimore, MD 21201
E-mail:  dhoffmann@
law.umaryland.edu
